An award-winning pathologist who devoted his life to melanoma research became the first person to receive a novel ...

For celebrated research in small cell lung cancer, including the development of circulating tumor cell-derived explant ... test and novel treatment for giant nevi that have significantly advanced ...

Mahfoud, W., Bouya, M., Haitami, S. and Ben Yahya, I. (2025) Conservative Management of an Odontogenic Myxoma of the Mandible: A Case Report and Literature Review. Open Access Library Journal, 12, 1-1 ...

The Food and Drug Administration (FDA) has approved Romvimza ™ (vimseltinib) for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will ...

A committee consisting of Dr. Codman, Dr. Ewing and Dr. Bloodgood studied a large number of cases of bone tumors, and from them they separated a group of benign giant-cell tumors. Up to that time ...

Oncolytic adenovirus was engineered for the forced ectopic delivery of peptide-MHC ligand of T cell receptors (TCRs) to ...

Prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors Treatment of adults and skeletally mature adolescents with giant cell ...

A total of 209 patients received upadacitinib at a dose of 15 mg, 107 received upadacitinib at a dose of 7.5 mg, and 112 received placebo; 70% of the patients had new-onset giant-cell arteritis ...

Glioblastoma, one of the most aggressive and lethal brain cancers, has a five-year survival rate of only 6.9%, according to the National Brain Tumor Society. While the relationship between ...

The results showed that the metastases had significantly lower levels of LAMP2A compared to the primary tumors. Similar patterns ... underlying causes of cancer cell spread.

Their study, published in Nature Metabolism, reveals how metabolic reprogramming can boost T-cell survival and efficacy in the tumor microenvironment. The immune system – composed of lymph nodes, the ...